69 related articles for article (PubMed ID: 2890090)
21. [Application of serum markers in medullary thyroid carcinoma].
Han XD; Lu RQ; Hu HY; Guo L
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1468-1474. PubMed ID: 34963245
[No Abstract] [Full Text] [Related]
22. Strumal carcinoids of the ovary. An immunohistologic and ultrastructural study.
Stagno PA; Petras RE; Hart WR
Arch Pathol Lab Med; 1987 May; 111(5):440-6. PubMed ID: 3551874
[TBL] [Abstract][Full Text] [Related]
23. [Detection of remnants after removal of medullary thyroid carcinoma].
Zhang J; Dai W; Lian X; Meng X; Hu Y; Bai Y; Li F; Zhang B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):19-21. PubMed ID: 11831978
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma.
Vainas I; Koussis Ch; Pazaitou-Panayiotou K; Drimonitis A; Chrisoulidou A; Iakovou I; Boudina M; Kaprara A; Maladaki A
J Exp Clin Cancer Res; 2004 Dec; 23(4):549-59. PubMed ID: 15743023
[TBL] [Abstract][Full Text] [Related]
26. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
[TBL] [Abstract][Full Text] [Related]
27. An immunohistochemical study in thyroid cancer.
Beltrami CA; Barbatelli G; Criante P; Paliaga A; Amadi CE
Appl Pathol; 1987; 5(4):229-45. PubMed ID: 2446641
[TBL] [Abstract][Full Text] [Related]
28. Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma.
Matsubayashi S; Yanaihara C; Ohkubo M; Fukata S; Hayashi Y; Tamai H; Nakagawa T; Miyauchi A; Kuma K; Abe K
Cancer; 1984 Jun; 53(11):2472-7. PubMed ID: 6370416
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical and ultrastructural analysis of medullary carcinoma of the thyroid in relation to hormone production.
Kameya T; Shimosato Y; Adachi I; Abe K; Kasai N; Kimura K; Baba K
Am J Pathol; 1977 Dec; 89(3):555-74. PubMed ID: 202164
[TBL] [Abstract][Full Text] [Related]
31. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.
Sikri KL; Varndell IM; Hamid QA; Wilson BS; Kameya T; Ponder BA; Lloyd RV; Bloom SR; Polak JM
Cancer; 1985 Nov; 56(10):2481-91. PubMed ID: 2412687
[TBL] [Abstract][Full Text] [Related]
32. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.
Scopsi L; Di Palma S; Ferrari C; Holst JJ; Rehfeld JF; Rilke F
Mod Pathol; 1991 May; 4(3):297-304. PubMed ID: 1676840
[TBL] [Abstract][Full Text] [Related]
33. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors.
Yamaguchi K; Abe K; Kameya T; Adachi I; Taguchi S; Otsubo K; Yanaihara N
Cancer Res; 1983 Aug; 43(8):3932-9. PubMed ID: 6861155
[TBL] [Abstract][Full Text] [Related]
34. Immunohistological studies of medullary thyroid carcinoma and C cell hyperplasia.
Deftos LJ; Bone HG; Parthemore JG
J Clin Endocrinol Metab; 1980 Oct; 51(4):857-62. PubMed ID: 6106648
[TBL] [Abstract][Full Text] [Related]
35. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
36. Medullary carcinoma of the thyroid gland: an immunocytochemical study.
Holm R; Sobrinho-Simões M; Nesland JM; Gould VE; Johannessen JV
Ultrastruct Pathol; 1985; 8(1):25-41. PubMed ID: 3901454
[TBL] [Abstract][Full Text] [Related]
37. Calcitonin, somatostatin and ACTH immunoreactive cells in a case of familial bilateral thyroid medullary carcinoma.
Charpin C; Andrac L; Monier-Faugere MC; Hassoun J; Cannoni M; Vagneur JP; Toga M
Cancer; 1982 Nov; 50(9):1806-14. PubMed ID: 6126268
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content.
Schröder S; Böcker W; Baisch H; Bürk CG; Arps H; Meiners I; Kastendieck H; Heitz PU; Klöppel G
Cancer; 1988 Feb; 61(4):806-16. PubMed ID: 2448025
[TBL] [Abstract][Full Text] [Related]
39. The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases.
Krisch K; Krisch I; Horvat G; Neuhold N; Ulrich W
Histopathology; 1985 Oct; 9(10):1077-89. PubMed ID: 2417931
[TBL] [Abstract][Full Text] [Related]
40. [Gastrointestinal hormone profile in medullary thyroid carcinoma].
Wirth HP; Eberle C; Meyenberger C; Bertschinger P; Häcki WH; Ammann R; Heitz PU
Schweiz Med Wochenschr; 1994 May; 124(21):906-11. PubMed ID: 8016606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
